Investor Shelf

Funder directory / Spain / Venture capital firms

Ysios Capital

Venture capitalBarcelona, Spainysioscapital.comVerified 9 Nov 2026

Ysios Capital is a life sciences venture capital firm that invests globally in biotechnology companies. The firm focuses on funding biotech ventures developing novel therapeutic drugs and technologies from company creation through late preclinical and clinical development stages.

StagesSeed · Series A · Series B+
Invests inEurope · US
Deals recorded34
Fund sizeWe manage over €400M ($500M ) in assets across three glob…quoted from their site

What they invest in

  • We are a leading life sciences investor financing highly innovative companies worldwide. source
  • We provide biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs. source
  • We invest globally in biotech ventures, focusing exclusively on innovative therapeutic drugs. source

All investments and operations

34 operations
CompanyRoundAmountDateCo-investorsSource
Adcendo
DK
––––Portfolio page
AELIX Therapeutics
ES
––––Portfolio page
AM Pharma
NL
––––Portfolio page
Anaconda Biomed
ES
––––Portfolio page
Aura Biosciences
US
––––Portfolio page
Babyscripts
US
––––Portfolio page
BioVex
US
––––Portfolio page
CorWave
FR
––––Portfolio page
CVRx
US
––––Portfolio page
Cytoki Pharma
DK
––––Portfolio page
Show all 34 operations

Exits

  • TiGenix Acquired by Takeda Pharmaceuticals2018 · Source
  • AM Pharma Acquired by Ambrose HealthcareSource
  • BioVex Acquired by AmgenSource
  • EndoSense Acquired by St Jude Medical/AbbottSource
  • Fusion Pharmaceuticals Acquired by AstrazenecaSource
  • AELIX Therapeutics Acquired by Gilead SciencesSource
  • Neurona Therapeutics Acquired by UCBSource
  • Sanifit Acquired by Vifor PharmaSource
  • STAT Dx Acquired by QiagenSource
  • Memo Therapeutics Acquired by IPSENSource

Shown only when an exit is documented by a public source.

Similar funders